John Barr Joins Nitinotes as New Chairman

Nitinotes proudly announces Mr. John Barr as our new Board Chairman.
Bringing over 40 years of MedTech experience, especially in obesity treatment, John joins us at a crucial juncture following our Series B funding success and CL0010 trial progress.